Company intelligence / Profile preview

Vynca

Palo Alto, California, United States

Ownership: Private
Development stage: Other

Overview

Currently operating at commercial scale with 600,000+ patient care plans across 11 states. Organizations using the platform have achieved a 37% reduction in hospital admissions, 59% reduction in ICU utilization, and 2x increase in completed end-of-life documents. Over 100 hospitals and the first health plan have adopted the solution.

Therapeutic areas: OtherCardiovascularNeurologyPulmonologyGastroenterologyOncology
Modalities: Non-pharmacological therapy (palliative care delivery model)
Industry: Non-Academic Healthcare

Partnerships

Oregon Health and Science University (co-development partner)

Beyond the preview

Go deeper on Vynca.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Vynca.

Explore the full profile